https://www.selleckchem.com/pr....oducts/bersacapavir.
working remotely (OR = 1.29, 95% CI 1.16-1.44/OR = 1.35, 95% CI 1.23-1.47). Reductions, although smaller, were also seen for PWB. Scores in the SF-36 bodily pain subscale decreased from 85.8 ± 18.7% pre-restrictions to 81.3 ± 21.9% during restrictions. Clinically relevant decrements of PWB were associated with female **** (OR = 1.62, 95% CI 1.50-1.75), high levels of public life restrictions (OR = 1.26, 95% CI 1.18-1.36), and young age (OR = 1.10, 95% CI 1.03-1.19). Study findings suggest lockdowns instituted during the COVID-19 pan
Like
Comment
Share
